Exact Mass: 492.26175700000005
Exact Mass Matches: 492.26175700000005
Found 500 metabolites which its exact mass value is equals to given mass value 492.26175700000005
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Erinacine P
Erinacine P is found in mushrooms. Erinacine P is a metabolite of Hericium erinaceum (lions mane) and Hericium ramosu Metabolite of Hericium erinaceum (lions mane) and Hericium ramosum. Erinacine P is found in mushrooms.
Sordarin
D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors
Bezitramide
C31H32N4O2 (492.25251319999995)
N - Nervous system > N02 - Analgesics > N02A - Opioids > N02AC - Diphenylpropylamine derivatives D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent D002491 - Central Nervous System Agents > D000700 - Analgesics
Lurasidone
Vorapaxar
C29H33FN2O4 (492.24242300000003)
PA(2:0/18:1(12Z)-O(9S,10R))
PA(2:0/18:1(12Z)-O(9S,10R)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(2:0/18:1(12Z)-O(9S,10R)), in particular, consists of one chain of one acetyl at the C-1 position and one chain of 9,10-epoxy-octadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
PA(18:1(12Z)-O(9S,10R)/2:0)
PA(18:1(12Z)-O(9S,10R)/2:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:1(12Z)-O(9S,10R)/2:0), in particular, consists of one chain of one 9,10-epoxy-octadecenoyl at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
PA(2:0/18:1(9Z)-O(12,13))
PA(2:0/18:1(9Z)-O(12,13)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(2:0/18:1(9Z)-O(12,13)), in particular, consists of one chain of one acetyl at the C-1 position and one chain of 12,13-epoxy-octadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
PA(18:1(9Z)-O(12,13)/2:0)
PA(18:1(9Z)-O(12,13)/2:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:1(9Z)-O(12,13)/2:0), in particular, consists of one chain of one 12,13-epoxy-octadecenoyl at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
Kushenol B
Kushenol B is a member of flavanones. Kushenol B is a natural product found in Sophora and Sophora flavescens with data available.
Kadlongilactone B
A hexacyclic triterpenoid isolated from the leaves and stems of Kadsura longipedunculata and has been found to exhibit cytotoxicity aganist human tumour cells.
Macaflavanone G
A trihydroxyflavanone that is (2S)-flavanone substituted by hydroxy groups at positions 5, 7 and 4, a prenyl group at position 6 and a (2S)-2-methyl-2-(4-methylpent-3-en-1-yl)tetrahydro-2H-pyran ring fused across positions 2 and 3. Isolated from the leaves of Macaranga tanarius, it exhibits antineoplastic activity.
2,4,6,3-Tetrahydroxy-3-geranyl-6,6-dimethylpyrano[2,3:4,5]dihydrochalcone
Propolin G
(-)-Nymphaeol C|(-)-Nymphaeol-C|5,7,3,4-tetrahydroxy-6-(3,3-dimethylallyl)-2-C-geranylflavanone|5,7,3,4-tetrahydroxy-6-(3,3-dimethylallyl)-2-geranylflavanone|Nymphaeol C|nymphaeol-C|propolin G
4H-1,16-Etheno-5,15-(propaniminoethano)furo[3,4-l][1,5,10]triazacyclohexadecine-4,21-dione, 3,3a,6,7,8,9,10,11,12,13,14,15-dodecahydro-3-(4-hydroxyphenyl)-
(E)-1,3-dihydroxy-6,7-dimethoxy-2-(3-methylbut-2-enyl)-8-(3,7-dimethyl-2,6-octadienyl)xanthone|6-O-methylcowanin
1beta-hydroxypregna-5,16-dien-3alpha-ol-20-one 3-O-beta-D-glucopyranoside|tupichinin A
lespeflorin B4
A trihydroxyflavanone that is (2S)-flavanone substituted by hydroxy groups at positions 3, 5, 7 and 4 and prenyl groups at positions 6, 8 and 3. Isolated from the roots of Lespedeza floribunda, it acts as a melanin synthesis inhibitor.
Cyclo-(D-phenylalanyl=>L-phenylalanyl=>D-valyl=>L-valyl)
Sanggenol P
5,7,2,4-tetrahydroxyl-6,8,5-tri-(gamma,gamma-dimethylallyl)isoflavanone|6,8,5-tri-(gamma,gamma-dimethylallyl)dalbergioidin|ormosinol
1-[1-(acetyloxy)ethyl]octahydro-4-methylidene-6-[(2-methylpropanoyl)oxy]-2-oxo-7-(propan-2-yl)-1H-inden-5-yl (2E)-4-hydroxy-3-methylpent-2-enoate
tetradehydro-17,4,5,6 3alpha cinchophylline
C31H32N4O2 (492.25251319999995)
Ala Phe Gln Lys
Ala Phe Lys Gln
Ala Lys Phe Gln
Ala Lys Gln Phe
Ala Gln Phe Lys
Ala Gln Lys Phe
Cys Lys Arg Ser
Cys Lys Ser Arg
Cys Arg Lys Ser
Cys Arg Ser Lys
Cys Ser Lys Arg
Cys Ser Arg Lys
Asp Phe Ile Val
Asp Phe Leu Val
Asp Phe Val Ile
Asp Phe Val Leu
Asp Ile Phe Val
Asp Ile Val Phe
Asp Leu Phe Val
Asp Leu Val Phe
Asp Val Phe Ile
Asp Val Phe Leu
Asp Val Ile Phe
Asp Val Leu Phe
Glu Phe Val Val
Glu Val Phe Val
Glu Val Val Phe
Phe Ala Lys Gln
Phe Ala Gln Lys
Phe Asp Ile Val
Phe Asp Leu Val
Phe Asp Val Ile
Phe Asp Val Leu
Phe Glu Val Val
Phe Gly Asn Arg
C21H32N8O6 (492.24446919999997)
Phe Gly Arg Asn
C21H32N8O6 (492.24446919999997)
Phe Ile Asp Val
Phe Ile Val Asp
Phe Lys Ala Gln
Phe Lys Gln Ala
Phe Leu Asp Val
Phe Leu Val Asp
Phe Met Pro Val
C24H36N4O5S (492.24062860000004)
Phe Met Val Pro
C24H36N4O5S (492.24062860000004)
Phe Asn Gly Arg
C21H32N8O6 (492.24446919999997)
Phe Asn Arg Gly
C21H32N8O6 (492.24446919999997)
Phe Pro Met Val
C24H36N4O5S (492.24062860000004)
Phe Pro Val Met
C24H36N4O5S (492.24062860000004)
Phe Gln Ala Lys
Phe Gln Lys Ala
Phe Arg Gly Asn
C21H32N8O6 (492.24446919999997)
Phe Arg Asn Gly
C21H32N8O6 (492.24446919999997)
Phe Val Asp Ile
Phe Val Asp Leu
Phe Val Glu Val
Phe Val Ile Asp
Phe Val Leu Asp
Phe Val Met Pro
C24H36N4O5S (492.24062860000004)
Phe Val Pro Met
C24H36N4O5S (492.24062860000004)
Phe Val Val Glu
Gly Phe Asn Arg
C21H32N8O6 (492.24446919999997)
Gly Phe Arg Asn
C21H32N8O6 (492.24446919999997)
Gly Asn Phe Arg
C21H32N8O6 (492.24446919999997)
Gly Asn Arg Phe
C21H32N8O6 (492.24446919999997)
Gly Arg Phe Asn
C21H32N8O6 (492.24446919999997)
Gly Arg Asn Phe
C21H32N8O6 (492.24446919999997)
His His Ile Ser
C21H32N8O6 (492.24446919999997)
His His Leu Ser
C21H32N8O6 (492.24446919999997)
His His Ser Ile
C21H32N8O6 (492.24446919999997)
His His Ser Leu
C21H32N8O6 (492.24446919999997)
His His Thr Val
C21H32N8O6 (492.24446919999997)
His His Val Thr
C21H32N8O6 (492.24446919999997)
His Ile His Ser
C21H32N8O6 (492.24446919999997)
His Ile Ser His
C21H32N8O6 (492.24446919999997)
His Leu His Ser
C21H32N8O6 (492.24446919999997)
His Leu Ser His
C21H32N8O6 (492.24446919999997)
His Ser His Ile
C21H32N8O6 (492.24446919999997)
His Ser His Leu
C21H32N8O6 (492.24446919999997)
His Ser Ile His
C21H32N8O6 (492.24446919999997)
His Ser Leu His
C21H32N8O6 (492.24446919999997)
His Thr His Val
C21H32N8O6 (492.24446919999997)
His Thr Val His
C21H32N8O6 (492.24446919999997)
His Val His Thr
C21H32N8O6 (492.24446919999997)
His Val Thr His
C21H32N8O6 (492.24446919999997)
Ile Asp Phe Val
Ile Asp Val Phe
Ile Phe Asp Val
Ile Phe Val Asp
Ile His His Ser
C21H32N8O6 (492.24446919999997)
Ile His Ser His
C21H32N8O6 (492.24446919999997)
Ile Met Met Val
C21H40N4O5S2 (492.24399900000003)
Ile Met Val Met
C21H40N4O5S2 (492.24399900000003)
Ile Pro Thr Tyr
Ile Pro Tyr Thr
Ile Ser His His
C21H32N8O6 (492.24446919999997)
Ile Thr Pro Tyr
Ile Thr Tyr Pro
Ile Val Asp Phe
Ile Val Phe Asp
Ile Val Met Met
C21H40N4O5S2 (492.24399900000003)
Ile Tyr Pro Thr
Ile Tyr Thr Pro
Lys Ala Phe Gln
Lys Ala Gln Phe
Lys Cys Arg Ser
Lys Cys Ser Arg
Lys Phe Ala Gln
Lys Phe Gln Ala
Lys Lys Met Ser
C20H40N6O6S (492.27299000000005)
Lys Lys Ser Met
C20H40N6O6S (492.27299000000005)
Lys Met Lys Ser
C20H40N6O6S (492.27299000000005)
Lys Met Ser Lys
C20H40N6O6S (492.27299000000005)
Lys Gln Ala Phe
Lys Gln Phe Ala
Lys Arg Cys Ser
Lys Arg Ser Cys
Lys Ser Cys Arg
Lys Ser Lys Met
C20H40N6O6S (492.27299000000005)
Lys Ser Met Lys
C20H40N6O6S (492.27299000000005)
Lys Ser Arg Cys
Leu Asp Phe Val
Leu Asp Val Phe
Leu Phe Asp Val
Leu Phe Val Asp
Leu His His Ser
C21H32N8O6 (492.24446919999997)
Leu His Ser His
C21H32N8O6 (492.24446919999997)
Leu Met Met Val
C21H40N4O5S2 (492.24399900000003)
Leu Met Val Met
C21H40N4O5S2 (492.24399900000003)
Leu Pro Thr Tyr
Leu Pro Tyr Thr
Leu Ser His His
C21H32N8O6 (492.24446919999997)
Leu Thr Pro Tyr
Leu Thr Tyr Pro
Leu Val Asp Phe
Leu Val Phe Asp
Leu Val Met Met
C21H40N4O5S2 (492.24399900000003)
Leu Tyr Pro Thr
Leu Tyr Thr Pro
Met Phe Pro Val
C24H36N4O5S (492.24062860000004)
Met Phe Val Pro
C24H36N4O5S (492.24062860000004)
Met Ile Met Val
C21H40N4O5S2 (492.24399900000003)
Met Ile Val Met
C21H40N4O5S2 (492.24399900000003)
Met Lys Lys Ser
C20H40N6O6S (492.27299000000005)
Met Lys Ser Lys
C20H40N6O6S (492.27299000000005)
Met Leu Met Val
C21H40N4O5S2 (492.24399900000003)
Met Leu Val Met
C21H40N4O5S2 (492.24399900000003)
Met Met Ile Val
C21H40N4O5S2 (492.24399900000003)
Met Met Leu Val
C21H40N4O5S2 (492.24399900000003)
Met Met Val Ile
C21H40N4O5S2 (492.24399900000003)
Met Met Val Leu
C21H40N4O5S2 (492.24399900000003)
Met Pro Phe Val
C24H36N4O5S (492.24062860000004)
Met Pro Val Phe
C24H36N4O5S (492.24062860000004)
Met Ser Lys Lys
C20H40N6O6S (492.27299000000005)
Met Val Phe Pro
C24H36N4O5S (492.24062860000004)
Met Val Ile Met
C21H40N4O5S2 (492.24399900000003)
Met Val Leu Met
C21H40N4O5S2 (492.24399900000003)
Met Val Met Ile
C21H40N4O5S2 (492.24399900000003)
Met Val Met Leu
C21H40N4O5S2 (492.24399900000003)
Met Val Pro Phe
C24H36N4O5S (492.24062860000004)
Asn Phe Gly Arg
C21H32N8O6 (492.24446919999997)
Asn Phe Arg Gly
C21H32N8O6 (492.24446919999997)
Asn Gly Phe Arg
C21H32N8O6 (492.24446919999997)
Asn Gly Arg Phe
C21H32N8O6 (492.24446919999997)
Asn Arg Phe Gly
C21H32N8O6 (492.24446919999997)
Asn Arg Gly Phe
C21H32N8O6 (492.24446919999997)
Pro Phe Met Val
C24H36N4O5S (492.24062860000004)
Pro Phe Val Met
C24H36N4O5S (492.24062860000004)
Pro Ile Thr Tyr
Pro Ile Tyr Thr
Pro Leu Thr Tyr
Pro Leu Tyr Thr
Pro Met Phe Val
C24H36N4O5S (492.24062860000004)
Pro Met Val Phe
C24H36N4O5S (492.24062860000004)
Pro Thr Ile Tyr
Pro Thr Leu Tyr
Pro Thr Tyr Ile
Pro Thr Tyr Leu
Pro Val Phe Met
C24H36N4O5S (492.24062860000004)
Pro Val Met Phe
C24H36N4O5S (492.24062860000004)
Pro Tyr Ile Thr
Pro Tyr Leu Thr
Pro Tyr Thr Ile
Pro Tyr Thr Leu
Gln Ala Phe Lys
Gln Ala Lys Phe
Gln Phe Ala Lys
Gln Phe Lys Ala
Gln Lys Ala Phe
Gln Lys Phe Ala
Arg Cys Lys Ser
Arg Cys Ser Lys
Arg Phe Gly Asn
C21H32N8O6 (492.24446919999997)
Arg Phe Asn Gly
C21H32N8O6 (492.24446919999997)
Arg Gly Phe Asn
C21H32N8O6 (492.24446919999997)
Arg Gly Asn Phe
C21H32N8O6 (492.24446919999997)
Arg Lys Cys Ser
Arg Lys Ser Cys
Arg Asn Phe Gly
C21H32N8O6 (492.24446919999997)
Arg Asn Gly Phe
C21H32N8O6 (492.24446919999997)
Arg Ser Cys Lys
Arg Ser Lys Cys
Ser Cys Lys Arg
Ser Cys Arg Lys
Ser His His Ile
C21H32N8O6 (492.24446919999997)
Ser His His Leu
C21H32N8O6 (492.24446919999997)
Ser His Ile His
C21H32N8O6 (492.24446919999997)
Ser His Leu His
C21H32N8O6 (492.24446919999997)
Ser Ile His His
C21H32N8O6 (492.24446919999997)
Ser Lys Cys Arg
Ser Lys Lys Met
C20H40N6O6S (492.27299000000005)
Ser Lys Met Lys
C20H40N6O6S (492.27299000000005)
Ser Lys Arg Cys
Ser Leu His His
C21H32N8O6 (492.24446919999997)
Ser Met Lys Lys
C20H40N6O6S (492.27299000000005)
Ser Arg Cys Lys
Ser Arg Lys Cys
Thr His His Val
C21H32N8O6 (492.24446919999997)
Thr His Val His
C21H32N8O6 (492.24446919999997)
Thr Ile Pro Tyr
Thr Ile Tyr Pro
Thr Leu Pro Tyr
Thr Leu Tyr Pro
Thr Pro Ile Tyr
Thr Pro Leu Tyr
Thr Pro Tyr Ile
Thr Pro Tyr Leu
Thr Val His His
C21H32N8O6 (492.24446919999997)
Thr Tyr Ile Pro
Thr Tyr Leu Pro
Thr Tyr Pro Ile
Thr Tyr Pro Leu
Val Asp Phe Ile
Val Asp Phe Leu
Val Asp Ile Phe
Val Asp Leu Phe
Val Glu Phe Val
Val Glu Val Phe
Val Phe Asp Ile
Val Phe Asp Leu
Val Phe Glu Val
Val Phe Ile Asp
Val Phe Leu Asp
Val Phe Met Pro
C24H36N4O5S (492.24062860000004)
Val Phe Pro Met
C24H36N4O5S (492.24062860000004)
Val Phe Val Glu
Val His His Thr
C21H32N8O6 (492.24446919999997)
Val His Thr His
C21H32N8O6 (492.24446919999997)
Val Ile Asp Phe
Val Ile Phe Asp
Val Ile Met Met
C21H40N4O5S2 (492.24399900000003)
Val Leu Asp Phe
Val Leu Phe Asp
Val Leu Met Met
C21H40N4O5S2 (492.24399900000003)
Val Met Phe Pro
C24H36N4O5S (492.24062860000004)
Val Met Ile Met
C21H40N4O5S2 (492.24399900000003)
Val Met Leu Met
C21H40N4O5S2 (492.24399900000003)
Val Met Met Ile
C21H40N4O5S2 (492.24399900000003)
Val Met Met Leu
C21H40N4O5S2 (492.24399900000003)
Val Met Pro Phe
C24H36N4O5S (492.24062860000004)
Val Pro Phe Met
C24H36N4O5S (492.24062860000004)
Val Pro Met Phe
C24H36N4O5S (492.24062860000004)
Val Thr His His
C21H32N8O6 (492.24446919999997)
Val Val Glu Phe
Val Val Phe Glu
Tyr Ile Pro Thr
Tyr Ile Thr Pro
Tyr Leu Pro Thr
Tyr Leu Thr Pro
Tyr Pro Ile Thr
Tyr Pro Leu Thr
Tyr Pro Thr Ile
Tyr Pro Thr Leu
Tyr Thr Ile Pro
Tyr Thr Leu Pro
Tyr Thr Pro Ile
Tyr Thr Pro Leu
Herical
29-demethylgeodisterol-O-sulfite
C27H40O6S (492.25454600000006)
Vorapaxar
C29H33FN2O4 (492.24242300000003)
B - Blood and blood forming organs > B01 - Antithrombotic agents > B01A - Antithrombotic agents > B01AC - Platelet aggregation inhibitors excl. heparin C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors C78274 - Agent Affecting Cardiovascular System COVID info from Guide to PHARMACOLOGY Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
lurasidone
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AE - Indole derivatives D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist
tert-Butyl 4-(5-chloro-1-(triisopropylsilyl)-1H-pyrrolo[2,3-b]pyridin-4-yl)piperazine-1-carboxylate
(3alpha,5beta,7alpha,12Alpha)-3,7,12-tris(formyloxy)cholan-24-oic acid
ethyl ((1R,3aR,4aR,6R,8aR,9S,9aS)-9-((E)-2-(5-(3-fluorophenyl)pyridin-2-yl)vinyl)-1-methyl-3-oxododecahydronaphtho[2,3-c]furan-6-yl)carbamate
C29H33FN2O4 (492.24242300000003)
3,6-Dibenzyl-9,12-di(propan-2-yl)-1,4,7,10-tetrazacyclododecane-2,5,8,11-tetrone
Bezitramide
C31H32N4O2 (492.25251319999995)
N - Nervous system > N02 - Analgesics > N02A - Opioids > N02AC - Diphenylpropylamine derivatives D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent D002491 - Central Nervous System Agents > D000700 - Analgesics
(1S,3aR,4S,4aR,7R,7aR,8aS)-8a-{[(6-deoxy-4-O-methyl-beta-D-altropyranosyl)oxy]methyl}-4-formyl-7-methyl-3-(propan-2-yl)-4,4a,5,6,7,7a,8,8a-octahydro-1,4-methano-s-indacene-3a(1H)-carboxylic acid
D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors
ethyl N-[9-[(E)-2-[5-(3-fluorophenyl)pyridin-2-yl]ethenyl]-1-methyl-3-oxo-3a,4,4a,5,6,7,8,8a,9,9a-decahydro-1H-benzo[f][2]benzofuran-6-yl]carbamate
C29H33FN2O4 (492.24242300000003)
[(2R)-1-acetyloxy-3-phosphonooxypropan-2-yl] (Z)-11-(3-pentyloxiran-2-yl)undec-9-enoate
[(2R)-2-acetyloxy-3-phosphonooxypropyl] (Z)-11-(3-pentyloxiran-2-yl)undec-9-enoate
Nymphaeol C
A tetrahydroxyflavanone that is (2S)-flavanone substituted by hydroxy group at positions 5, 7, 3 and 4, a geranyl group at position 2 and a prenyl group at position 6. Isolated from Macaranga tanarius and propolis collected in Okinawa, it exhibits radical scavenging activity.
schizolaenone B
A tetrahydroxyflavanone that is (2S)-flavanone substituted by hydroxy groups at positions 5, 7, 4 and 5, a geranyl group at position 3 and a prenyl group at position 6. Isolated from Schizolaena hystrix, it exhibits cytotoxicity against ovarian cancer cell line.
Asp-Leu-Phe-Val
A tetrapeptide composed of L-aspartic acid, L-leucine, L-phenylalanine and L-valine joined in sequence by peptide linkages.
3-[[4-(diphenylmethyl)-1-piperazinyl]-oxomethyl]-7,8,9,10-tetrahydro-6H-azepino[2,1-b]quinazolin-12-one
C31H32N4O2 (492.25251319999995)
3-[(1-tert-butyl-5-tetrazolyl)-[2-furanylmethyl(2-oxolanylmethyl)amino]methyl]-6-methoxy-1H-quinolin-2-one
1-[[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-(3-phenylprop-1-ynyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propylurea
3beta-hydroxy-16alpha,17alpha-epoxypregnenolone 3-beta-D-glucoside
An epoxy steroid that is 3beta-hydroxypregnenolone 3-beta-D-glucoside in which the hydrogens at the 16alpha and 17alpha positions have been replaced by the oxygen of the epoxide ring.
(2S)-2-[(4S,5R)-4-methyl-5-[[methyl(4-oxanylmethyl)amino]methyl]-1,1-dioxo-8-pent-1-ynyl-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C26H40N2O5S (492.26577900000007)
(2R)-2-[(4R,5R)-4-methyl-5-[[methyl(4-oxanylmethyl)amino]methyl]-1,1-dioxo-8-pent-1-ynyl-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C26H40N2O5S (492.26577900000007)
(2S)-2-[(4R,5R)-4-methyl-5-[[methyl(4-oxanylmethyl)amino]methyl]-1,1-dioxo-8-pent-1-ynyl-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C26H40N2O5S (492.26577900000007)
(2S,3S)-8-[2-(1-hydroxycyclopentyl)ethynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(2-pyridinylmethyl)amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(1R,9S,10S,11S)-12-(2-cyclopropylacetyl)-N-[3-(dimethylamino)propyl]-10-(hydroxymethyl)-6-oxo-5-phenyl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
(2R)-2-[(4S,5R)-4-methyl-5-[[methyl(4-oxanylmethyl)amino]methyl]-1,1-dioxo-8-pent-1-ynyl-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C26H40N2O5S (492.26577900000007)
(2S)-2-[(4S,5S)-4-methyl-5-[[methyl(4-oxanylmethyl)amino]methyl]-1,1-dioxo-8-pent-1-ynyl-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C26H40N2O5S (492.26577900000007)
(2R)-2-[(4R,5S)-4-methyl-5-[[methyl(4-oxanylmethyl)amino]methyl]-1,1-dioxo-8-pent-1-ynyl-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C26H40N2O5S (492.26577900000007)
(2R)-2-[(4S,5S)-4-methyl-5-[[methyl(4-oxanylmethyl)amino]methyl]-1,1-dioxo-8-pent-1-ynyl-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C26H40N2O5S (492.26577900000007)
(2S)-2-[(4R,5S)-4-methyl-5-[[methyl(4-oxanylmethyl)amino]methyl]-1,1-dioxo-8-pent-1-ynyl-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C26H40N2O5S (492.26577900000007)
(2S,3S)-8-[2-(1-hydroxycyclopentyl)ethynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(2-pyridinylmethyl)amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2R,3R)-8-[2-(1-hydroxycyclopentyl)ethynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(2-pyridinylmethyl)amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2S,3R)-8-[2-(1-hydroxycyclopentyl)ethynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(2-pyridinylmethyl)amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2R,3R)-8-[2-(1-hydroxycyclopentyl)ethynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(2-pyridinylmethyl)amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2R,3S)-8-[2-(1-hydroxycyclopentyl)ethynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(2-pyridinylmethyl)amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2S,3R)-8-[2-(1-hydroxycyclopentyl)ethynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(2-pyridinylmethyl)amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(1S,9R,10R,11R)-11-(4-benzylpiperidine-1-carbonyl)-10-(hydroxymethyl)-6-oxo-N-propyl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-12-carboxamide
(2R,3R,3aS,9bS)-3-(hydroxymethyl)-1-methyl-N-(3-morpholin-4-ylpropyl)-6-oxo-7-[(E)-2-phenylethenyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
(2S,3S,3aR,9bR)-N1-cyclopentyl-N2-(cyclopropylmethyl)-3-(hydroxymethyl)-6-oxo-7-(5-pyrimidinyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-1,2-dicarboxamide
N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-(1-methyl-3-indolyl)acetamide
N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-(1-methyl-3-indolyl)acetamide
N-[[(2S,3R)-8-(1-cyclohexenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-pyridin-4-ylacetamide
N-[[(2R,3R)-8-(1-cyclohexenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-pyridin-4-ylacetamide
1-[[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-(3-phenylprop-1-ynyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propylurea
N-[[(2R,3S)-8-(1-cyclohexenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-pyridin-4-ylacetamide
N-[[(2S,3S)-8-(1-cyclohexenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-pyridin-4-ylacetamide
1-[[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-(3-phenylprop-1-ynyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propylurea
1-[[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-(3-phenylprop-1-ynyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propylurea
1-[[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-(3-phenylprop-1-ynyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propylurea
N-[[(2R,3R)-8-(1-cyclohexenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-pyridin-4-ylacetamide
N-[[(2R,3S)-8-(1-cyclohexenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-pyridin-4-ylacetamide
N-[[(2R,3S)-8-[3-(dimethylamino)prop-1-ynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-phenylacetamide
N-[[(2R,3S)-8-[3-(dimethylamino)prop-1-ynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-phenylacetamide
N-[[(2S,3S)-8-[3-(dimethylamino)prop-1-ynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-phenylacetamide
(2R)-2-[(4R,5S)-8-(1-cyclopentenyl)-4-methyl-5-[[methyl(4-oxanylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C26H40N2O5S (492.26577900000007)
(2S)-2-[(4R,5S)-8-(1-cyclopentenyl)-4-methyl-5-[[methyl(4-oxanylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C26H40N2O5S (492.26577900000007)
(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(4-oxanylmethyl)amino]methyl]-8-(2-pyridin-4-ylethynyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2R,3R,3aS,9bS)-N1-cyclopentyl-N2-(cyclopropylmethyl)-3-(hydroxymethyl)-6-oxo-7-(5-pyrimidinyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-1,2-dicarboxamide
(1S)-1-(hydroxymethyl)-7-methoxy-1-[oxo(2-pyrazinyl)methyl]-N-propan-2-yl-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]carboxamide
N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-(1-methyl-3-indolyl)acetamide
(2R,3S)-8-[2-(1-hydroxycyclopentyl)ethynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(2-pyridinylmethyl)amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
N-[[(2S,3R)-8-(1-cyclohexenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-pyridin-4-ylacetamide
N-[[(2S,3S)-8-(1-cyclohexenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-pyridin-4-ylacetamide
1-[[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-(3-phenylprop-1-ynyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propylurea
1-[[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-(3-phenylprop-1-ynyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propylurea
1-[[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-(3-phenylprop-1-ynyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propylurea
(2S)-4-[(4R,5S)-5-[[cyclohexylmethyl(methyl)amino]methyl]-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-8-yl]-3-butyn-2-ol
C26H40N2O5S (492.26577900000007)
N-[[(2R,3R)-8-[3-(dimethylamino)prop-1-ynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-phenylacetamide
N-[[(2S,3R)-8-[3-(dimethylamino)prop-1-ynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-phenylacetamide
N-[[(2S,3R)-8-[3-(dimethylamino)prop-1-ynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-phenylacetamide
N-[[(2S,3S)-8-[3-(dimethylamino)prop-1-ynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-phenylacetamide
N-[[(2R,3R)-8-[3-(dimethylamino)prop-1-ynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-phenylacetamide
(2R)-2-[(4S,5S)-8-(1-cyclopentenyl)-4-methyl-5-[[methyl(4-oxanylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C26H40N2O5S (492.26577900000007)
(2S)-2-[(4R,5R)-8-(1-cyclopentenyl)-4-methyl-5-[[methyl(4-oxanylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C26H40N2O5S (492.26577900000007)
(2S)-2-[(4S,5R)-8-(1-cyclopentenyl)-4-methyl-5-[[methyl(4-oxanylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C26H40N2O5S (492.26577900000007)
(2S)-2-[(4S,5S)-8-(1-cyclopentenyl)-4-methyl-5-[[methyl(4-oxanylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C26H40N2O5S (492.26577900000007)
(2R)-2-[(4S,5R)-8-(1-cyclopentenyl)-4-methyl-5-[[methyl(4-oxanylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C26H40N2O5S (492.26577900000007)
(2R)-2-[(4R,5R)-8-(1-cyclopentenyl)-4-methyl-5-[[methyl(4-oxanylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C26H40N2O5S (492.26577900000007)
(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(4-oxanylmethyl)amino]methyl]-8-(2-pyridin-4-ylethynyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(4-oxanylmethyl)amino]methyl]-8-(2-pyridin-4-ylethynyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(1R,9S,10S,11S)-11-(4-benzylpiperidine-1-carbonyl)-10-(hydroxymethyl)-6-oxo-N-propyl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-12-carboxamide
(2S,3S,3aR,9bR)-3-(hydroxymethyl)-1-methyl-N-(3-morpholin-4-ylpropyl)-6-oxo-7-[(E)-2-phenylethenyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
(1S,9R,10R,11R)-12-(2-cyclopropylacetyl)-N-[3-(dimethylamino)propyl]-10-(hydroxymethyl)-6-oxo-5-phenyl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
(1R)-2-(cyclopropylmethyl)-N-(3-fluorophenyl)-1-(hydroxymethyl)-7-methoxy-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]carboxamide
(1S)-2-(cyclopropylmethyl)-N-(3-fluorophenyl)-1-(hydroxymethyl)-7-methoxy-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]carboxamide
(1R)-1-(hydroxymethyl)-7-methoxy-1-[oxo(2-pyrazinyl)methyl]-N-propan-2-yl-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]carboxamide
2-(dimethylamino)-1-[(1S)-1-(hydroxymethyl)-7-methoxy-9-methyl-1-(5-pyrimidinylmethyl)-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]ethanone
C27H36N6O3 (492.28487459999997)